<SEC-DOCUMENT>0001104659-25-019184-index.html : 20250228 <SEC-HEADER>0001104659-25-019184.hdr.sgml : 20250228 <ACCEPTANCE-DATETIME>20250228163717 ACCESSION NUMBER: 0001104659-25-019184 CONFORMED SUBMISSION TYPE: S-3 PUBLIC DOCUMENT COUNT: 6 FILED AS OF DATE: 20250228 DATE AS OF CHANGE: 20250228 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Outlook Therapeutics, Inc. CENTRAL INDEX KEY: 0001649989 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 383982704 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: S-3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-285438 FILM NUMBER: 25691091 BUSINESS ADDRESS: STREET 1: 111 S. WOOD AVENUE STREET 2: UNIT #100 CITY: ISELIN STATE: NJ ZIP: 08830 BUSINESS PHONE: 6096193990 MAIL ADDRESS: STREET 1: 111 S. WOOD AVENUE STREET 2: UNIT #100 CITY: ISELIN STATE: NJ ZIP: 08830 FORMER COMPANY: FORMER CONFORMED NAME: Oncobiologics, Inc. DATE OF NAME CHANGE: 20150804 </SEC-HEADER> <DOCUMENT> <TYPE>S-3 <SEQUENCE>1 <FILENAME>tm257774d1_s3.htm <DESCRIPTION>FORM S-3 <TEXT> Document 1 - file: tm257774d1_s3.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>2 <FILENAME>tm257774d1_ex5-1.htm <DESCRIPTION>EXHIBIT 5.1 <TEXT> Document 2 - file: tm257774d1_ex5-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>3 <FILENAME>tm257774d1_ex23-1.htm <DESCRIPTION>EXHIBIT 23.1 <TEXT> Document 3 - file: tm257774d1_ex23-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-FILING FEES <SEQUENCE>4 <FILENAME>tm257774d1_ex-filingfees.htm <DESCRIPTION>EX-FILING FEES <TEXT> Document 4 - file: tm257774d1_ex-filingfees.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>tm257774d1_ex5-1img001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: tm257774d1_ex5-1img001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>tm257774d1_s3img001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 6 - file: tm257774d1_s3img001.jpg
</DOCUMENT> </SEC-DOCUMENT>